Semaglutide for Weight Loss Cost in Phoenix, AZ
Semaglutide for Weight Loss in Phoenix typically costs $203 to $1,428, with a median price of $357. That places Phoenix 2% above the national average for this procedure in 2026.
Get matched with Semaglutide for Weight Loss clinics in Phoenix, AZ
Free, no obligation. We send your request to 2-4 verified clinics for quotes and financing options.
How much does semaglutide for weight loss cost in Phoenix, AZ in 2026? Semaglutide for Weight Loss in Phoenix, AZ costs between $203 and $1,428 in 2026, with most patients paying around $357 (per month all-inclusive (medication + provider + supplies)). This is 2% above the national average (national median: $350). Pricing varies based on brand-name wegovy or ozempic vs compounded, dose level, telehealth subscription vs in-person, plus provider experience and facility type.
What Semaglutide for Weight Loss Is
Semaglutide is a synthetic version of GLP-1, a hormone naturally produced by the gut after eating that signals fullness and regulates blood sugar. As a weight-loss medication, semaglutide is delivered as a once-weekly subcutaneous injection. The starting dose is typically 0.25 mg per week, titrated upward over 4 to 5 months to 1.7 to 2.4 mg per week depending on tolerance and response.
Who It Is For
Wegovy is FDA-approved for adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related condition such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea. In clinical practice, semaglutide is also widely prescribed to adults with BMI 25-30 for cosmetic weight loss, off-label, particularly through telehealth weight-loss clinics. Patients with personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 should not take semaglutide.
What Is Typically Included in Phoenix Pricing
Most Phoenix-area quotes for Semaglutide for Weight Loss include the items below. Always request a written inclusion list before booking.
- Medical provider consultation and prescription
- Monthly medication shipment (semaglutide in vial or pre-filled syringes)
- Syringes and supplies for self-injection
- Provider messaging for dose adjustments
- Side effect management protocols
- Some clinics include initial bloodwork
Often Not Included (Verify Before Booking)
- Initial baseline bloodwork (some clinics charge separately, $50-$150)
- Specialty consultations if side effects require
- Nutrition coaching or program structure (some premium clinics add this)
- Long-term maintenance after weight loss goal is reached (often dose reduction continues)
Procedure Snapshot
- Category
- Weight Loss
- Total timeline
- 30 days
- Typical recovery
- 0 days
- National range
- $199 - $1,400
- Phoenix range
- $203 - $1,428
- Cost unit
- per month all-inclusive (medication + provider + supplies)
- Financing common
- No
- Evidence level
- FDA-Approved
What Drives Semaglutide for Weight Loss Cost in Phoenix
These factors most commonly move Semaglutide for Weight Loss pricing up or down in the Phoenix market. Ask Phoenix clinics about each item when comparing quotes.
Brand-name Wegovy or Ozempic vs compounded
Brand-name retail without insurance runs $1,300+/month. Compounded semaglutide from licensed 503A pharmacies through telehealth clinics runs $199-$499/month, a 60-85 percent discount.
Dose level
Higher maintenance doses (1.7-2.4 mg/week) cost more than starting doses (0.25-0.5 mg/week). Most clinics tier pricing by dose level.
Telehealth subscription vs in-person
Telehealth (Henry Meds, Mochi Health, Calibrate, Sequence, Ro Body) $199-$499/month. In-person medical weight-loss clinics $400-$700/month with optional nutrition and accountability coaching.
Insurance coverage
Wegovy is covered by some commercial insurance plans, often with prior authorization. Out-of-pocket can be as low as $0-$50 with insurance approval. Medicare does not cover for obesity (only for diabetes via Ozempic).
Compounding pharmacy quality
Higher-end 503A pharmacies (with full sterility testing, certificate of analysis available) may charge $50-$200 more than budget compounders. Discount providers may use lower-quality APIs.
Bundled wellness services
Premium GLP-1 programs (Mochi, Sequence, Calibrate) include dietitian coaching, lifestyle support, and continuous care for $300-$600/month total.
Insurance and Coverage for Semaglutide for Weight Loss in Phoenix
Insurance coverage for semaglutide varies dramatically by plan, employer, and indication. Wegovy (branded for obesity) is covered by many commercial plans with prior authorization requiring documented BMI 30+ or 27+ with comorbidities. Medicare currently does not cover any obesity medication, including Wegovy. Ozempic (branded for diabetes) is broadly covered for type 2 diabetes patients. Compounded versions are generally not covered.
Typical coverage: Wegovy: 70-100% after deductible if covered. Often $25-$100 monthly copay.
Prior authorization typically required.
State-specific notes
International Cost Comparison
How Semaglutide for Weight Loss pricing in Phoenix compares to major international medical tourism destinations. Quality, credentialing, and follow-up logistics vary substantially - verification is critical before traveling for care.
| Country / City | Typical Cost | Notes | Pros / Cons |
|---|---|---|---|
| Canada (Toronto / Vancouver) | $300-$400/month brand-name | Ozempic and Wegovy are available in Canada at lower retail pricing than US, though importation in personal-use quantities for US residents is legally constrained. | + Lower brand-name pricing - Importation legal limits; not for ongoing US-resident use |
| United Kingdom (NHS or private) | £175-£275/month private | Wegovy is available privately through Boots Online Doctor and similar UK telehealth. NHS Wegovy access is limited to specialist weight-management clinics. | + Tight regulatory framework on private provision - Travel/customs complexity for US patients |
| Mexico (Border pharmacies) | $200-$350/month brand-name | Wegovy and Ozempic available at Mexican pharmacies. Importation legal limits apply. | + Lower price; available without US prescription - Quality and chain-of-custody concerns; not recommended for long-term US-resident use without US clinical oversight |
| Australia (Sydney / Melbourne) | AUD$280-$450/month | PBS (Pharmaceutical Benefits Scheme) does not cover Wegovy for obesity; full retail pricing. | + Quality regulatory framework - High cost without PBS subsidy |
Pre-Procedure Checklist
Steps to complete before your scheduled semaglutide for weight loss to maximize outcomes and minimize complications.
- Verify no personal or family history of medullary thyroid cancer or MEN2 syndrome.
- Disclose history of pancreatitis or severe gallbladder disease.
- List all current medications, especially other diabetes medications or insulin.
- Verify clinic uses an FDA-registered 503A or 503B pharmacy.
- Confirm API is FDA-approved semaglutide (not a salt form).
- Get current weight and body measurements documented.
- Set up resistance training schedule for muscle preservation.
- Plan structured protein intake (at least 80g/day).
- Discuss family planning timeline (pregnancy not advised on GLP-1).
- Calculate total monthly cost and verify payment plan.
How the Procedure Works
Step-by-step overview of Semaglutide for Weight Loss.
- 1
Initial screening and medical history
15-30 minutes (online or in-person)Most clinics screen for thyroid cancer history, gallbladder disease, pancreatitis history, and pregnancy. Some require baseline bloodwork (CBC, CMP, lipids, A1c).
- 2
Provider consultation
20-30 minutesLicensed provider reviews history, discusses goals, explains protocol and side effects, prescribes semaglutide.
- 3
Medication delivery
3-7 days shippingMedication shipped from licensed pharmacy. Initial shipment includes injection training instructions or video.
- 4
Weekly self-injection
30 seconds/weekPatient self-administers weekly subcutaneous injection (abdomen, thigh, or arm). Starting dose 0.25 mg, titrating up every 4 weeks.
- 5
Dose titration
4-5 months to maintenance doseDose increases every 4 weeks: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg/week (Wegovy schedule). Compounded protocols may use simplified or modified schedules.
- 6
Maintenance and monitoring
OngoingOngoing weekly injection at maintenance dose. Periodic check-ins with provider. Some patients maintain dose long-term; others taper after reaching weight goal.
Recovery Timeline
What to expect day by day and month by month after Semaglutide for Weight Loss.
Aftercare and Long-Term Maintenance
Recommended care after semaglutide for weight loss to maintain results and prevent complications.
Patient Experience: What to Expect
Composite patient experiences across stages of the semaglutide for weight loss journey, drawn from aggregated reported experiences and clinical observation.
Most patients spend weeks researching before starting, often after years of unsuccessful weight loss attempts. Common research touch points: comparing telehealth clinics (Henry Meds, Mochi, Calibrate, Ro Body), reading about brand vs compounded options, and watching others post results on TikTok and Reddit. Many patients arrive with strong opinions about specific clinics or compounding pharmacies.
Most patients describe the first injection as anticlimactic - the needle is small, the injection takes seconds, and there is minimal sensation. The bigger psychological event is the recognition that this is the start of a long-term commitment.
Appetite suppression typically begins within 3-5 days. Patients describe "food noise" reduction - the constant background thinking about eating subsides dramatically. Many lose 3-7 pounds in the first 2 weeks. Mild nausea, particularly after large or fatty meals, is common.
Each 4-week dose increase brings a wave of side effects (nausea, fatigue, constipation) that subside over 1-2 weeks. Patients describe the titration phase as the hardest part of the journey. Weight loss is typically 1-2 pounds per week through this period.
Most patients describe the maintenance dose as remarkably stable. Side effects are minimal. Weight continues to decline at roughly 0.5-1 pound per week, slowing over time. Many patients note social and identity shifts: clothes no longer fit, others comment on changes, food relationships are different.
Most patients reach a weight plateau between month 9 and 15, at 12-17% body weight loss. The big decision is whether to continue indefinitely at maintenance dose, reduce dose, or attempt to stop. The published evidence suggests stopping leads to substantial weight regain.
Risks and Complications
Documented risks and their typical frequency in published clinical data.
Nausea
commonAffects 30-45 percent of patients, particularly during dose titration. Typically mild to moderate and subsides over 1-2 weeks at each dose level. Managed with smaller meals, low-fat foods, and slow dose titration.
Vomiting and diarrhea
commonAffects 15-25 percent of patients. Usually mild and self-limiting.
Constipation
commonAffects 20-30 percent of patients. Managed with hydration, fiber, magnesium, or stool softeners.
Gallbladder disease
uncommonRoughly 1-2 percent of patients develop gallstones or cholecystitis, particularly with rapid weight loss. Acute symptoms require medical evaluation.
Pancreatitis
rareLess than 0.5 percent. Severe abdominal pain radiating to the back requires immediate medical evaluation.
Thyroid C-cell tumors
unconfirmed in humansAnimal studies showed medullary thyroid tumors. No confirmed cases in humans. Contraindicated for patients with personal or family history of medullary thyroid cancer or MEN2.
Loss of lean muscle mass
commonApproximately 25-40 percent of weight loss on semaglutide is lean mass (not fat). Resistance training and adequate protein intake during treatment mitigate this.
Rebound weight gain after stopping
very commonStudies show 60-70 percent of lost weight is regained within 12-24 months of discontinuation. Long-term maintenance or robust lifestyle changes are needed.
Alternatives to Semaglutide for Weight Loss
Other approaches to the same condition or goal, with cost and tradeoff comparisons.
Tirzepatide (Zepbound, Mounjaro)
Dual GIP/GLP-1 agonist. Slightly higher average weight loss (18-22 percent vs 12-17 percent for semaglutide) in published trials. Similar side effect profile.
Phentermine
Older stimulant appetite suppressant. Much cheaper and oral but typically only used short-term (12 weeks per FDA labeling). Less weight loss (5-10 percent).
Bariatric surgery
Surgical option with greater long-term weight loss (25-35 percent) but invasive and irreversible. More appropriate for BMI 35+ with comorbidities.
Lifestyle intervention alone
Diet and exercise without medication. Typically produces 3-5 percent weight loss in 12 months with high rates of regain. Less effective than medication for sustained obesity.
Semaglutide for Weight Loss Cost Comparison Across Metros
See how Semaglutide for Weight Loss pricing in Phoenix compares to nearby and major US markets.
Provider Credentials Guide for Semaglutide for Weight Loss
Which credentials matter most when selecting a Phoenix provider for semaglutide for weight loss, and how to verify them.
State-licensed MD, DO, NP, or PA
criticalHow to verify: Verify via your state medical board. Telehealth providers must be licensed in your state.
Obesity Medicine Board Certification (ABOM)
importantHow to verify: Verify at the American Board of Obesity Medicine directory. ABOM-certified providers have deeper training in obesity pharmacotherapy.
Use of FDA-registered 503A or 503B compounding pharmacy
criticalHow to verify: Ask the clinic which pharmacy fills compounded prescriptions. Verify pharmacy is licensed in your state via the National Association of Boards of Pharmacy.
Use of FDA-approved active pharmaceutical ingredient (API)
criticalHow to verify: Compounded semaglutide must use FDA-approved semaglutide as the API, NOT semaglutide salt forms (acetate, sodium). Ask for a certificate of analysis.
Nutrition and lifestyle support
helpfulHow to verify: Higher-touch clinics include registered dietitian or coaching support. Useful for muscle preservation and long-term success.
Clear titration and monitoring protocol
importantHow to verify: Ask for the written titration schedule. Reputable clinics follow the published Wegovy schedule or a clear modified protocol.
Red Flags When Choosing a Phoenix Clinic
Patterns to watch for when comparing Semaglutide for Weight Loss providers.
- No initial provider consultation or screening for contraindications.
- Bulk multi-month shipments without monitoring.
- Compounding pharmacy is not licensed or refuses to provide credentials.
- Use of "salt forms" (semaglutide acetate or sodium) which are not FDA-approved APIs.
- No discussion of long-term plan or maintenance.
- Refusal to discuss alternatives or appropriate use of medication.
- Pricing far below market ($99/month or less) often indicates lower-quality compounding.
- No mechanism to reach a licensed provider for side effects.
Questions to Ask Any Phoenix Provider
Use this list during consultations. Reputable providers will answer all of them clearly and in writing.
- Is this prescribed semaglutide from a 503A or 503B licensed pharmacy?
- Is the API (active ingredient) FDA-approved semaglutide, or a salt form?
- What is the full titration protocol you use?
- How do you handle nausea or side effects during titration?
- What is the plan after reaching maintenance dose - do I stay on indefinitely?
- How do you support muscle mass preservation during weight loss?
- What labs do you check, and how often?
- What is the all-inclusive monthly cost?
- What happens if my insurance changes - can I continue with you?
- How do you handle taper or discontinuation?
Frequently Asked Questions
Answers to the most-searched questions about Semaglutide for Weight Loss cost and treatment.
How much does semaglutide cost per month in 2026? +
Brand-name Wegovy retails at approximately $1,300 per month without insurance in 2026. Compounded semaglutide from licensed 503A pharmacies through telehealth weight-loss clinics typically runs $199 to $499 per month, a 60 to 85 percent discount. With insurance coverage for Wegovy, out-of-pocket can be $0 to $50 with prior authorization. Medicare does not cover for obesity but does cover Ozempic for type 2 diabetes.
How much weight will I lose on semaglutide? +
Published clinical trials show average weight loss of 12 to 17 percent of starting body weight at 68 weeks on the maximum dose (2.4 mg/week). For a 220-pound starting weight, that is approximately 26 to 37 pounds. Results vary significantly: some patients lose 25+ percent, others lose under 5 percent. Roughly 85 percent of patients achieve at least 5 percent weight loss; about 50 percent achieve at least 15 percent.
Is compounded semaglutide safe? +
Compounded semaglutide from licensed 503A pharmacies using FDA-approved active pharmaceutical ingredients is widely considered safe by clinicians, though it carries less manufacturing oversight than brand-name Wegovy. Risks include variable potency, contamination, and use of unapproved "salt forms" (semaglutide acetate or sodium) by lower-quality compounders. Verify your clinic uses an FDA-registered 503A pharmacy and asks about API source. Avoid pharmacies that cannot provide certificate of analysis.
How long do I have to stay on semaglutide? +
Studies show 60 to 70 percent of weight lost on semaglutide is regained within 12 to 24 months of stopping. Most patients require ongoing maintenance dosing (often at reduced dose) to maintain weight loss long-term, or robust lifestyle changes including resistance training, structured nutrition, and behavioral support. Semaglutide is generally considered a long-term or indefinite medication for chronic weight management, similar to medications for high blood pressure or diabetes.
What are the side effects of semaglutide? +
The most common side effects are gastrointestinal: nausea (30-45 percent), constipation (20-30 percent), diarrhea (15-25 percent), and vomiting (15-25 percent). Side effects are typically mild to moderate and most pronounced during dose increases, then subside over 1-2 weeks at each dose level. Rare but serious side effects include gallbladder disease (1-2 percent), pancreatitis (less than 0.5 percent), and theoretical risk of thyroid C-cell tumors (not confirmed in humans).
Will I lose muscle on semaglutide? +
Approximately 25 to 40 percent of weight lost on semaglutide is lean mass (muscle, organ tissue, connective tissue) rather than fat, similar to the muscle loss seen with severe calorie restriction. Resistance training 2-3 times per week and adequate protein intake (1.0-1.2 grams per kg body weight) during semaglutide use substantially mitigate muscle loss. Some clinics now bundle nutritional and exercise coaching for this reason.
Can I drink alcohol on semaglutide? +
Alcohol is not contraindicated with semaglutide but is often poorly tolerated. Many patients report dramatically reduced alcohol cravings and tolerance on GLP-1 medications - a phenomenon currently being studied as a potential therapy for alcohol use disorder. Some patients report intensified hangovers or stomach upset from drinking on semaglutide.
Does insurance cover semaglutide? +
Coverage varies widely. Many commercial insurance plans cover Wegovy for obesity (BMI 30+) with prior authorization, often requiring documented attempts at lifestyle change. Medicare does not cover Wegovy for obesity but covers Ozempic for diabetes. Medicaid coverage varies by state. Some employers exclude obesity medications from formularies. Compounded semaglutide is generally not covered by insurance.
How is semaglutide injected? +
Semaglutide is injected subcutaneously (under the skin, not into muscle) once weekly. Common injection sites are the abdomen (at least 2 inches from the navel), the front of the thigh, or the back of the upper arm. Brand-name Wegovy comes in pre-filled pens with a fixed dose; compounded semaglutide is typically drawn from a multi-dose vial into a syringe.
What is the difference between Wegovy, Ozempic, and compounded semaglutide? +
All three contain the same active molecule (semaglutide). Wegovy is FDA-approved for weight management at doses up to 2.4 mg/week. Ozempic is FDA-approved for type 2 diabetes at doses up to 2.0 mg/week. Compounded semaglutide is prepared by 503A pharmacies in custom dosing, typically in multi-dose vials. Brand-name products are manufactured under FDA pharmaceutical standards; compounded versions are subject to USP compounding standards which are similar but not identical.
Is semaglutide safe for type 1 diabetes? +
Semaglutide is not approved for type 1 diabetes and is generally not recommended due to risk of severe hypoglycemia when combined with insulin. Always discuss with your endocrinologist before considering GLP-1 medication if you have type 1 diabetes.
What is the difference between semaglutide and tirzepatide? +
Semaglutide is a single-agonist GLP-1 medication. Tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) is a dual-agonist targeting both GLP-1 and GIP receptors. Tirzepatide shows slightly greater average weight loss in trials (18-22 percent vs 12-17 percent for semaglutide). Both have similar side effect profiles and similar pricing structures (brand $1,000-$1,300/month, compounded $200-$500/month).
Will semaglutide affect my mood or mental health? +
Most patients report stable or improved mood on semaglutide. Some report transient low mood, particularly during titration. There have been case reports and ongoing investigation of rare suicidal ideation reports on GLP-1 medications, though large studies have not confirmed a causal relationship. Discuss with your provider if you have a history of severe depression or suicidality.
Glossary of Terms
Key terminology used throughout this page.
- GLP-1 (Glucagon-Like Peptide-1)
- A natural hormone produced by the gut after eating that signals fullness and regulates blood sugar. Semaglutide and tirzepatide are synthetic analogs.
- GIP (Glucose-dependent Insulinotropic Polypeptide)
- A second incretin hormone. Tirzepatide is a dual GLP-1/GIP agonist; semaglutide acts only on GLP-1.
- Compounded medication
- A custom-prepared medication made by a licensed pharmacy. 503A pharmacies prepare individualized prescriptions; 503B outsourcing facilities prepare larger batches.
- API (Active Pharmaceutical Ingredient)
- The active substance in a medication. For semaglutide, only FDA-approved API is acceptable; salt forms (acetate, sodium) are not FDA-approved.
- Titration
- Gradual dose increase to allow the body to acclimate to the medication, minimize side effects, and reach the target maintenance dose.
- Food noise
- Colloquial term for constant background thinking about food. Significantly reduced on GLP-1 medications, a frequently-reported subjective effect.
- Lean mass preservation
- Maintaining muscle tissue during weight loss. Critical for metabolic health and long-term weight management. Requires resistance training and adequate protein.
- FDA shortage list
- A registry of medications in short supply. While on the list, 503A pharmacies can legally compound the medication. Semaglutide and tirzepatide were removed from the shortage list in 2025.
Head-to-Head Comparisons
Compare Semaglutide for Weight Loss directly to alternatives, with cost, evidence, and outcome side-by-side.
Clinical Outcome Data
Published outcome metrics for Semaglutide for Weight Loss drawn from peer-reviewed clinical literature and registry data.
Sources
Clinical evidence cited on this page. ProcedureFinder sources primary clinical research, FDA records, and major professional society guidelines.
- Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity" (STEP 1 trial). New England Journal of Medicine, 2021. (Primary efficacy data for weight loss)
- Lincoff AM, et al. "Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes" (SELECT trial). New England Journal of Medicine, 2023. (Cardiovascular outcomes in obesity)
- FDA. "Wegovy (semaglutide) injection 2.4 mg Prescribing Information." 2024. (Official product labeling and indications)
- Aronne LJ, et al. "Continued Treatment with Tirzepatide for Maintenance of Weight Reduction" (SURMOUNT-4 trial). JAMA, 2024. (Long-term maintenance of weight loss)
- Rubino D, et al. "Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance" (STEP 4). JAMA, 2021. (Weight regain after discontinuation)
- FDA. "FDA Determination Regarding Resolution of Semaglutide Shortage." 2025. (Shortage list status and compounding implications)
- Davies M, et al. "Semaglutide 2.4 mg Once a Week in Adults with Overweight or Obesity, and Type 2 Diabetes (STEP 2)." Lancet, 2021. (Efficacy in T2D + obesity population)
- Wadden TA, et al. "Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults with Overweight or Obesity (STEP 3)." JAMA, 2021. (Lifestyle adjunct outcomes)
How We Calculate Phoenix Pricing
The price ranges shown reflect cash-pay (out-of-pocket) pricing observed across Phoenix-area providers, adjusted for the local cost index of 1.02x the national average. National benchmark data is blended from provider price surveys, published procedure pricing, and patient-reported costs. Pricing reflects 2026 data and is updated quarterly.
Read our full methodology →Medical Disclaimer
The information on this page is educational. It is not medical advice and does not substitute for evaluation by a licensed provider. Cost ranges are estimates; individual quotes vary. Always consult a qualified clinician before making medical decisions.
More Weight Loss Resources
Ready to compare Phoenix providers?
Get matched with 2 to 4 verified semaglutide for weight loss providers in Phoenix. Free, no obligation, no spam.